4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Mode of Treatment: Market Size & Analysis
5.1. Overview
5.2. Drugs
5.3. Vaccines
6. Disease Indication: Market Size & Analysis
6.1. Overview
6.2. Tuberculosis
6.3. HIV/AIDS
6.4. Influenza
6.5. Hepatitis
6.6. Others
7. Distribution Channel: Market Size & Analysis
7.1. Overview
7.2. Hospital Pharmacy
7.3. Retail Pharmacy
7.4. Others
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Gilead Sciences, Inc.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. BioCryst Pharmaceuticals, Inc.
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. F. Hoffmann-La Roche AG
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Merck & Co., Inc.
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Johnson & Johnson
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Boehringer Ingelheim GmbH
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. GlaxoSmithKline plc
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Janssen Pharmaceutical
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Novartis International AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Astellas Pharma
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
List of Tables
Table 1. Global Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 2. Global Infectious Disease Therapeutics Market Value for Drugs, by Geography, 2021-2027 (USD Billion)
Table 3. Global Infectious Disease Therapeutics Market Value for Vaccines, by Geography, 2021-2027 (USD Billion)
Table 4. Global Infectious Disease Therapeutics Market Value, by Disease Indication, by Geography, 2021-2027 (USD Billion)
Table 5. Global Infectious Disease Therapeutics Market Value for Tuberculosis, by Geography, 2021-2027 (USD Billion)
Table 6. Global Infectious Disease Therapeutics Market Value for Hiv/Aids, by Geography, 2021-2027 (USD Billion)
Table 7. Global Infectious Disease Therapeutics Market Value for Influenza, by Geography, 2021-2027 (USD Billion)
Table 8. Global Infectious Disease Therapeutics Market Value for Hepatitis, by Geography, 2021-2027 (USD Billion)
Table 9. Global Infectious Disease Therapeutics Market Value for Others, by Geography, 2021-2027 (USD Billion)
Table 10. Global Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 11. Global Infectious Disease Therapeutics Market Value for Hospital Pharmacy, by Geography, 2021-2027 (USD Billion)
Table 12. Global Infectious Disease Therapeutics Market Value for Retail Pharmacy, by Geography, 2021-2027 (USD Billion)
Table 13. Global Infectious Disease Therapeutics Market Value for Others, by Geography, 2021-2027 (USD Billion)
Table 14. North America Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Table 15. North America Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 16. North America Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 17. North America Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 18. U.S Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 19. U.S Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 20. U.S Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 21. Canada Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 22. Canada Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 23. Canada Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 24. Europe Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Table 25. Europe Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 26. Europe Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 27. Europe Infectious Disease Therapeutics Market Value, Distribution Channel, 2021-2027 (USD Billion)
Table 28. Germany Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 29. Germany Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 30. Germany Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 31. U.K Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 32. U.K Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 33. U.K Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 34. France Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 35. France Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 36. France Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 37. Italy Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 38. Italy Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 39. Italy Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 40. Spain Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 41. Spain Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 42. Spain Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 43. Roe Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 44. Roe Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 45. Roe Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 46. Asia Pacific Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Table 47. Asia Pacific Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 48. Asia Pacific Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 49. Asia Pacific Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 50. China Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 51. China Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 52. China Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 53. India Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 54. India Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 55. India Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 56. Japan Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 57. Japan Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 58. Japan Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 59. Rest of APAC Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 60. Rest of APAC Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 61. Rest of APAC Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 62. Rest of World Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Table 63. Rest of World Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Table 64. Rest of World Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Table 65. Gilead Sciences, Inc: Financials
Table 66. Gilead Sciences, Inc: Products & Services
Table 67. Gilead Sciences, Inc: Recent Developments
Table 68. Biocryst Pharmaceuticals, Inc: Financials
Table 69. Biocryst Pharmaceuticals, Inc: Products & Services
Table 70. Biocryst Pharmaceuticals, Inc: Recent Developments
Table 71. F. Hoffmann-La Roche AG: Financials
Table 72. F. Hoffmann-La Roche AG: Products & Services
Table 73. F. Hoffmann-La Roche AG: Recent Developments
Table 74. Merck & Co., Inc: Financials
Table 75. Merck & Co., Inc: Products & Services
Table 76. Merck & Co., Inc: Recent Developments
Table 77. Johnson & Johnson: Financials
Table 78. Johnson & Johnson: Products & Services
Table 79. Johnson & Johnson: Recent Developments
Table 80. Boehringer Ingelheim GmbH: Financials
Table 81. Boehringer Ingelheim GmbH: Products & Services
Table 82. Boehringer Ingelheim GmbH: Recent Developments
Table 83. Glaxosmithkline Plc: Financials
Table 84. Glaxosmithkline Plc: Products & Services
Table 85. Glaxosmithkline Plc: Recent Developments
Table 86. Janssen Pharmaceutical: Financials
Table 87. Janssen Pharmaceutical: Products & Services
Table 88. Janssen Pharmaceutical: Recent Developments
Table 89. Novartis International AG: Financials
Table 90. Novartis International AG: Products & Services
Table 91. Novartis International AG: Recent Developments
Table 92. Astellas Pharma: Financials
Table 93. Astellas Pharma: Products & Services
Table 94. Astellas Pharma: Recent Developments
List of Figures
Chart. 1. Global Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 2. Global Infectious Disease Therapeutics Market Value for Drugs, by Geography, 2021-2027 (USD Billion)
Chart 3. Global Infectious Disease Therapeutics Market Value for Vaccines, by Geography, 2021-2027 (USD Billion)
Chart 4. Global Infectious Disease Therapeutics Market Value, by Disease Indication, by Geography, 2021-2027 (USD Billion)
Chart 5. Global Infectious Disease Therapeutics Market Value for Tuberculosis, by Geography, 2021-2027 (USD Billion)
Chart 6. Global Infectious Disease Therapeutics Market Value for Hiv/Aids, by Geography, 2021-2027 (USD Billion)
Chart 7. Global Infectious Disease Therapeutics Market Value for Influenza, by Geography, 2021-2027 (USD Billion)
Chart 8. Global Infectious Disease Therapeutics Market Value for Hepatitis, by Geography, 2021-2027 (USD Billion)
Chart 9. Global Infectious Disease Therapeutics Market Value for Others, by Geography, 2021-2027 (USD Billion)
Chart 10. Global Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 11. Global Infectious Disease Therapeutics Market Value for Hospital Pharmacy, by Geography, 2021-2027 (USD Billion)
Chart 12. Global Infectious Disease Therapeutics Market Value for Retail Pharmacy, by Geography, 2021-2027 (USD Billion)
Chart 13. Global Infectious Disease Therapeutics Market Value for Others, by Geography, 2021-2027 (USD Billion)
Chart 14. North America Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Chart 15. North America Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 16. North America Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 17. North America Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 18. U.S Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 19. U.S Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 20. U.S Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 21. Canada Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 22. Canada Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 23. Canada Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 24. Europe Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Chart 25. Europe Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 26. Europe Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 27. Europe Infectious Disease Therapeutics Market Value, Distribution Channel, 2021-2027 (USD Billion)
Chart 28. Germany Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 29. Germany Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 30. Germany Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 31. U.K Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 32. U.K Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 33. U.K Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 34. France Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 35. France Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 36. France Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 37. Italy Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 38. Italy Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 39. Italy Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 40. Spain Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 41. Spain Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 42. Spain Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 43. RoE Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 44. RoE Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 45. RoE Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 46. Asia Pacific Infectious Disease Therapeutics Market Value, by Country, 2021-2027 (USD Billion)
Chart 47. Asia Pacific Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 48. Asia Pacific Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 49. Asia Pacific Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 50. China Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 51. China Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 52. China Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 53. India Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 54. India Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 55. India Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 56. Japan Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 57. Japan Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 58. Japan Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 59. Rest of APAC Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 60. Rest of APAC Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 61. Rest of APAC Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)
Chart 62. Rest of World Infectious Disease Therapeutics Market Value, by Mode of Treatment, 2021-2027 (USD Billion)
Chart 63. Rest of World Infectious Disease Therapeutics Market Value, by Disease Indication, 2021-2027 (USD Billion)
Chart 64. Rest of World Infectious Disease Therapeutics Market Value, by Distribution Channel, 2021-2027 (USD Billion)